Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder

CONCLUSION: CLS is safe and effective short-term adjunctive therapy in patients with MDD with no other comorbid conditions. Trial registration ID:NCT04069819.PMID:34545997 | DOI:10.1111/cns.13731

Source: CNS Neuroscience and Therapeutics - September 21, 2021 Category: Neuroscience Authors: Mahmoud S Abdallah Ahmed N Ramadan Hend Omara-Reda Noha O Mansour Mohamed A Elsokary Hozaifa K Elsawah Shimaa Abdelsattar Zaki Hend E Abo Mansour Esraa M Mosalam Source Type: research